Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap

被引:22
|
作者
Gao, Jie [1 ]
Zhou, Wutie [1 ]
Chen, Bida [1 ]
Lin, Weiming [1 ]
Wu, Sifang [1 ]
Wu, Feng [1 ]
机构
[1] Guangzhou Med Univ, Peoples Hosp 3, Dept Resp Med, 1 Xuebei Ave, Huizhou 516002, Guangdong, Peoples R China
来源
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2017年 / 12卷
关键词
induced sputum cell counts; COPD; BHR; bronchodilator reversibility; asthma; asthma COPD overlap;
D O I
10.2147/COPD.S142466
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Cell count in induced sputum is a noninvasive biomarker to assess airway inflammation phenotypes. Accordingly, sputum cell counts are extensively used in the treatment of asthma and COPD. Nevertheless, the clinical application of sputum cell counts in patients with asthma-COPD overlap (ACO) remains elusive. The aim of this study was to investigate sputum cell counts in patients with ACO which are different from those in patients with asthma and COPD and also to examine the relationship between sputum cell counts in bronchial reversibility and bronchial hyperresponsiveness (BHR). Patients and methods: A total of 374 patients participated in the study, including 142 patients with asthma, 160 patients with COPD and 72 patients with ACO. All patients underwent the following tests on the same day: pulmonary function test (PFT), BHR test or bronchodilator reversibility test and inducing sputum. They were classified into the asthma group, COPD group or ACO group based on a clinical history, PFT values and BHR test or bronchodilator reversibility test. Results: The three groups had different PFT values (p<0.001) except for forced vital capacity (FVC) between the asthma and ACO groups (p=0.378). The sputum levels of eosinophil% were decreased in patients with COPD when compared with those in patients with asthma and ACO (p<0.001 and p<0.001, respectively). There was a difference in sputum neutrophil% and macrophage% counts among the three groups (p<0.001 and p<0.001, respectively); there was no difference in sputum eosinophil% counts between patients with ACO and asthma (p= 0.668) and there was no difference in the percentage of induced sputum cells between the stage of airway obstruction and the stage of BHR. Conclusion: The clinical relevance of this study provides evidence that sputum cell counts as an inflammatory biomarker could carry some information to distinguish ACO, asthma and COPD, and these biomarkers need more studies to provide diagnostic value in the differentiation between ACO, asthma and COPD.
引用
收藏
页码:2703 / 2710
页数:8
相关论文
共 50 条
  • [21] Biologicals for asthma in patients with asthma-COPD overlap
    Busse, William W.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (03): : 175 - 177
  • [22] Asthma or asthma-COPD overlap syndrome? - Reply
    Tay, Tunn R.
    Radhakrishna, Naghmeh
    Hew, Mark
    RESPIROLOGY, 2017, 22 (03) : 612 - +
  • [23] Characterization of Asthma-COPD Overlap in an Asthma Cohort
    Lipkin-Moore, Z.
    Gomez, J.
    Chupp, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [24] INVESTIGATION OF FRACTIONAL EXHALED NITRIC OXIDE LEVELS IN THE DIFFERENTIATION OF ASTHMA, COPD AND ASTHMA-COPD OVERLAP
    Akimoto, Takahiro
    Takazawa, Seiko
    Sekiya, Muneyuki
    Oota, Haruhiko
    Yoshimura, Kunihiko
    Kasagi, Satoshi
    RESPIROLOGY, 2018, 23 : 133 - 134
  • [25] Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD
    Chen, Feng-jia
    Huang, Xin-yan
    Liu, Yang-li
    Lin, Geng-peng
    Xie, Can-mao
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2385 - 2390
  • [26] Phenotypic characterization of asthma-COPD overlap syndrome: Comparison with asthma and COPD
    Inui, Toshiya
    Nakamoto, Keitaro
    Sada, Mitsuru
    Tsuji, Shingo
    Nakamura, Masuo
    Tanaka, Yasutaka
    Koide, Takashi
    Takata, Saori
    Yokoyama, Takuma
    Saraya, Takeshi
    Kurai, Daisuke
    Ishii, Haruyuki
    Wada, Hiroo
    Takizawa, Hajime
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [27] Factors Associated with Exacerbations in Patients with Asthma, COPD and Asthma-COPD Overlap
    Diab, N.
    Riley, S.
    Stanbrook, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [28] Fatigue, Depression, and Anxiety in Patients with COPD, Asthma and Asthma-COPD Overlap
    Hometowska, Henryka
    Klekowski, Jakub
    Swiatoniowska-Lonc, Natalia
    Jankowska-Polanska, Beata
    Chabowski, Mariusz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [29] Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
    Iwamoto, Hiroshi
    gao, Jing
    Koskela, Jukka
    Kinnula, Vuokko
    Kobayashi, Hideo
    Laitinen, Tarja
    Mazur, Witold
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (02) : 421 - 429
  • [30] Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
    Iwamoto, Hiroshi
    Gao, Jing
    Koskela, Jukka
    Kobayashi, Hideo
    Laitinen, Tarja
    Mazur, Witold
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42